Twist Bioscience

YTD

ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC.

CEO

Emily Marine Leproust

CEOEmily Marine Leproust

Employees

979

Employees979

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2013

Founded2013

Employees

979

Employees979

TWST Key Statistics

Market cap

9.99B

Market cap9.99B

Price-Earnings ratio

-68.29

Price-Earnings ratio-68.29

Dividend yield

—

Dividend yield—

Average volume

4.04M

Average volume4.04M

High today

$161.80

High today$161.80

Low today

$147.55

Low today$147.55

Open price

$159.54

Open price$159.54

Volume

2.65M

Volume2.65M

52 Week high

$219.71

52 Week high$219.71

52 Week low

$23.30

52 Week low$23.30

Stock Snapshot

The current Twist Bioscience(TWST) stock price is $151.36, with a market capitalization of 9.99B. The stock trades at a price-to-earnings (P/E) ratio of -68.29.

On 2026-10-13, Twist Bioscience(TWST) stock moved within a range of $147.55 to $161.80. With shares now at $151.36, the stock is trading +2.6% above its intraday low and -6.5% below the session's peak.

Trading activity shows a volume of 2.65M, compared to an average daily volume of 4.04M.

The stock's 52-week range extends from a low of $23.30 to a high of $219.71.

TWST News

Simply Wall St 6h

Should Biofoundry Market Growth Require Action From Twist Bioscience Investors?

Twist Bioscience has been identified as a key participant in the global biofoundry-as-a-service market, which is projected to reach US$4.38b by 2030, reflecting...

Simply Wall St 2d

Is Twist Bioscience Fairly Valued As Its Shares Rebound?

Twist Bioscience (TWST) is back on investor screens after a sharp single day move of 5.1%, following a volatile week that saw the share price drop 15.3%. That...

Investing.com 2d

Twist Bioscience CEO Emily Leproust sells $919,373 in stock - Investing.com

...

Analyst ratings

69%

of 13 ratings

Buy

69.2%

Hold

23.1%

Sell

7.7%

More TWST News

TipRanks 5d

Twist Bioscience initiated with a Hold at Jefferies

Jefferies initiated coverage of Twist Bioscience (TWST) with a Hold rating and $150 price target Twist is a synthetic biology company that manufactures syntheti...

Benzinga 7d

Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

Cathie Wood’s ARK Invest continued to reshuffle its healthcare portfolio Monday across its ETFs, selling heavily in Twist Bioscience Corp (NASDAQ:TWST) while di...

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

CRISPR

10x Genomics

IonQ

Rocket Lab Corporation

AMD

Moderna

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.